17-(5-hydroxyheptan-2-yl)-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,4,6,8,14,15-hexol
| Internal ID | acfdf9f2-9706-4557-9b05-ac3f05137af8 |
| Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Bile acids, alcohols and derivatives > Hydroxy bile acids, alcohols and derivatives |
| IUPAC Name | 17-(5-hydroxyheptan-2-yl)-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,4,6,8,14,15-hexol |
| SMILES (Canonical) | CCC(CCC(C)C1CC(C2(C1(CCC3C2(CC(C4C3(CCC(C4O)O)C)O)O)C)O)O)O |
| SMILES (Isomeric) | CCC(CCC(C)C1CC(C2(C1(CCC3C2(CC(C4C3(CCC(C4O)O)C)O)O)C)O)O)O |
| InChI | InChI=1S/C26H46O7/c1-5-15(27)7-6-14(2)16-12-20(30)26(33)24(16,4)11-9-19-23(3)10-8-17(28)22(31)21(23)18(29)13-25(19,26)32/h14-22,27-33H,5-13H2,1-4H3 |
| InChI Key | NEIZYFZZJIRBKP-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C26H46O7 |
| Molecular Weight | 470.60 g/mol |
| Exact Mass | 470.32435380 g/mol |
| Topological Polar Surface Area (TPSA) | 142.00 Ų |
| XlogP | 1.30 |
| Atomic LogP (AlogP) | 1.34 |
| H-Bond Acceptor | 7 |
| H-Bond Donor | 7 |
| Rotatable Bonds | 5 |
| There are no found synonyms. |
![2D Structure of 17-(5-hydroxyheptan-2-yl)-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,4,6,8,14,15-hexol](https://plantaedb.com/storage/docs/compounds/2023/11/1ab35410-849c-11ee-9751-17cdb67c26b8.jpg "2D Structure of 17-(5-hydroxyheptan-2-yl)-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,4,6,8,14,15-hexol")
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9649 | 96.49% |
| Caco-2 | - | 0.7662 | 76.62% |
| Blood Brain Barrier | + | 0.6500 | 65.00% |
| Human oral bioavailability | - | 0.5143 | 51.43% |
| Subcellular localzation | Lysosomes | 0.5498 | 54.98% |
| OATP2B1 inhibitior | - | 0.5804 | 58.04% |
| OATP1B1 inhibitior | + | 0.9003 | 90.03% |
| OATP1B3 inhibitior | + | 0.9533 | 95.33% |
| MATE1 inhibitior | - | 1.0000 | 100.00% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | - | 0.8119 | 81.19% |
| P-glycoprotein inhibitior | - | 0.6720 | 67.20% |
| P-glycoprotein substrate | + | 0.6302 | 63.02% |
| CYP3A4 substrate | + | 0.6843 | 68.43% |
| CYP2C9 substrate | + | 0.5955 | 59.55% |
| CYP2D6 substrate | - | 0.7294 | 72.94% |
| CYP3A4 inhibition | - | 0.7942 | 79.42% |
| CYP2C9 inhibition | - | 0.8576 | 85.76% |
| CYP2C19 inhibition | - | 0.7589 | 75.89% |
| CYP2D6 inhibition | - | 0.9471 | 94.71% |
| CYP1A2 inhibition | - | 0.7789 | 77.89% |
| CYP2C8 inhibition | - | 0.5863 | 58.63% |
| CYP inhibitory promiscuity | - | 0.9113 | 91.13% |
| UGT catelyzed | - | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.9000 | 90.00% |
| Carcinogenicity (trinary) | Non-required | 0.6937 | 69.37% |
| Eye corrosion | - | 0.9923 | 99.23% |
| Eye irritation | - | 0.9327 | 93.27% |
| Skin irritation | + | 0.5731 | 57.31% |
| Skin corrosion | - | 0.9056 | 90.56% |
| Ames mutagenesis | - | 0.7278 | 72.78% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.4416 | 44.16% |
| Micronuclear | - | 0.9400 | 94.00% |
| Hepatotoxicity | - | 0.6578 | 65.78% |
| skin sensitisation | - | 0.8032 | 80.32% |
| Respiratory toxicity | + | 0.6444 | 64.44% |
| Reproductive toxicity | + | 0.9333 | 93.33% |
| Mitochondrial toxicity | + | 0.9625 | 96.25% |
| Nephrotoxicity | - | 0.9143 | 91.43% |
| Acute Oral Toxicity (c) | III | 0.4543 | 45.43% |
| Estrogen receptor binding | + | 0.6766 | 67.66% |
| Androgen receptor binding | + | 0.7622 | 76.22% |
| Thyroid receptor binding | + | 0.5632 | 56.32% |
| Glucocorticoid receptor binding | + | 0.6703 | 67.03% |
| Aromatase binding | + | 0.7279 | 72.79% |
| PPAR gamma | - | 0.5000 | 50.00% |
| Honey bee toxicity | - | 0.7969 | 79.69% |
| Biodegradation | - | 0.6750 | 67.50% |
| Crustacea aquatic toxicity | - | 0.6200 | 62.00% |
| Fish aquatic toxicity | + | 0.9603 | 96.03% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.77% | 97.25% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 96.33% | 96.09% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 96.32% | 94.45% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 95.74% | 92.50% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 95.11% | 90.17% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 94.65% | 95.58% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 93.84% | 82.69% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 93.69% | 92.86% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 93.57% | 96.38% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.37% | 97.09% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 93.14% | 96.61% |
| CHEMBL240 | Q12809 | HERG | 92.92% | 89.76% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 92.68% | 98.05% |
| CHEMBL1994 | P08235 | Mineralocorticoid receptor | 91.70% | 100.00% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 91.31% | 87.16% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 90.60% | 99.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 90.34% | 95.89% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 90.12% | 98.75% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 89.87% | 95.00% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 89.14% | 85.31% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 87.83% | 95.71% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 87.71% | 98.10% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 87.30% | 96.47% |
| CHEMBL1871 | P10275 | Androgen Receptor | 87.12% | 96.43% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 87.01% | 94.45% |
| CHEMBL2581 | P07339 | Cathepsin D | 86.84% | 98.95% |
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 86.63% | 88.81% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 85.85% | 97.29% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 85.40% | 100.00% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 85.38% | 95.89% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 84.46% | 91.24% |
| CHEMBL268 | P43235 | Cathepsin K | 83.63% | 96.85% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 83.40% | 97.64% |
| CHEMBL4302 | P08183 | P-glycoprotein 1 | 83.25% | 92.98% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 82.72% | 91.03% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 82.27% | 93.56% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 81.98% | 97.50% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 81.92% | 100.00% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 81.82% | 96.90% |
| CHEMBL4482 | O96013 | Serine/threonine-protein kinase PAK 4 | 81.52% | 95.42% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 81.40% | 97.23% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 81.12% | 91.11% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 81.02% | 93.18% |
| CHEMBL3837 | P07711 | Cathepsin L | 80.72% | 96.61% |
| CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 80.51% | 99.17% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 80.30% | 97.14% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Werneria nubigena |
| PubChem | 162895150 |
| LOTUS | LTS0175860 |
| wikiData | Q105122390 |